Source: Marketscreener

Element Biosciences: Twist Bioscience Corporation and Element Biosciences, Inc. Expand Collaboration to Transform Next Generation Sequencing Workflows with Co-Developed End-To-End Solutions

Twist Bioscience Corporation and Element Biosciences, Inc. announced an expanded collaboration to enable Element's AVITI systems and Trinity flowcells with additional Twist library preparation and target enrichment workflows. This collaboration builds on existing relationship with Element, which has yielded Twist's on-market Element-native kit and 1-hour fast hybridization Trinity solution. Twist will have exclusive access to develop additional library prep and target enrichment workflows compatible with Element's Trinity sequencing technology, giving Element customers access to the uniformity, consistency and quality provided by NGS tools. This will further advance Twist and Element's shared goal to radically streamline hybrid capture processes both off and on the sequencer. With the expansion of co-development and commercial efforts, will be able to further serve critical markets such as agbio, population genomics and clinical research.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
250-500
Molly He's photo - Co-Founder & CEO of Element Biosciences

Co-Founder & CEO

Molly He

CEO Approval Rating

90/100

Read more